Syndax Pharmaceuticals Inc
SNDX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001395937
In the last 90 days, Syndax Pharmaceuticals Inc insiders filed 0 open-market purchases and 1 sale; 242 institutions reported holding it in 13F filings for Q2 2026, worth $2.36B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Syndax Pharmaceuticals Inc as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 216
- +8 vs. Q3 2024
- Shares held
- 98.0M
- +9.56M (+10.8%) vs. Q3 2024
- Total value
- $1.30B
- −$408.0M (−23.9%) vs. Q3 2024
- New holders
- 37
- 89 more added
- Sold out
- 29
- 60 more reduced
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SNDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 242 | $2.36B |
| Q1 2026 | 247 | $2.32B |
| Q4 2025 | 230 | $2.10B |
| Q3 2025 | 227 | $1.56B |
| Q2 2025 | 217 | $952.6M |
| Q1 2025 | 219 | $1.24B |
| Q4 2024 | 216 | $1.30B |
| Q3 2024 | 210 | $1.71B |
| Q2 2024 | 196 | $1.79B |
| Q1 2024 | 189 | $2.15B |
| Q4 2023 | 177 | $1.92B |
| Q3 2023 | 175 | $1.03B |
| Q2 2023 | 166 | $1.48B |
| Q1 2023 | 163 | $1.54B |
| Q4 2022 | 160 | $1.82B |
| Q3 2022 | 139 | $1.44B |
| Q2 2022 | 121 | $1.06B |
| Q1 2022 | 136 | $948.4M |
| Q4 2021 | 132 | $1.15B |
| Q3 2021 | 123 | $938.0M |
| Q2 2021 | 115 | $861.9M |
| Q1 2021 | 130 | $1.08B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Syndax Pharmaceuticals Inc; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Franklin Resources Inc | 1,766,859 | $23.4M | 0.01% | +3,582+0.2% | Added |
| Woodline Partners LP | 1,891,803 | $25.0M | 0.17% | −4,229−0.2% | Reduced |
| Point72 Asset Management, L.P. | 1,915,736 | $25.3M | 0.07% | −862,531−31.0% | Reduced |
| Geode Capital Management, LLC | 1,973,116 | $26.1M | 0.00% | −3,966−0.2% | Reduced |
| Kingdon Capital Management, L.L.C. | 2,000,000 | $26.4M | 4.52% | +1,000,000+100.0% | Added |
| Assenagon Asset Management S.A. | 2,064,456 | $27.3M | 0.05% | +1,598,428+343.0% | Added |
| Avoro Capital Advisors LLC | 2,275,000 | $30.1M | 0.43% | −1,613,437−41.5% | Reduced |
| Soleus Capital Management, L.P. | 2,492,000 | $32.9M | 2.49% | +1,401,016+128.4% | Added |
| StemPoint Capital LP | 2,872,601 | $38.0M | 9.52% | +1,141,410+65.9% | Added |
| State Street Corp | 3,917,516 | $51.8M | 0.00% | +146,690+3.9% | Added |
| Wellington Management Group LLP | 4,234,455 | $56.0M | 0.01% | −751,521−15.1% | Reduced |
| Vanguard Group Inc | 4,881,968 | $64.5M | 0.00% | −5,006−0.1% | Reduced |
| Morgan Stanley | 5,312,822 | $70.2M | 0.00% | +4,425,677+498.9% | Added |
| Goldman Sachs Group Inc | 5,950,537 | $78.7M | 0.02% | +4,338,485+269.1% | Added |
| Kynam Capital Management, LP | 8,520,000 | $112.6M | 7.43% | +2,677,075+45.8% | Added |
| BlackRock, Inc. | 9,033,949 | $119.4M | 0.00% | +794,899+9.6% | Added |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −1,925,300−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −937,250−100.0% | Sold out |
| Commodore Capital LP | 0 | $0 | 0.00% | −885,000−100.0% | Sold out |
| Foresite Capital Management IV, LLC | 0 | $0 | 0.00% | −875,000−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −350,206−100.0% | Sold out |
| Peregrine Capital Management LLC | 0 | $0 | 0.00% | −199,086−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −87,997−100.0% | Sold out |
| T. Rowe Price Investment Management, Inc. | 0 | $0 | 0.00% | −85,511−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −79,341−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −66,403−100.0% | Sold out |
| Artia Global Partners LP | 0 | $0 | 0.00% | −48,263−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −43,070−100.0% | Sold out |
| NVWM, LLC | 0 | $0 | 0.00% | −42,475−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −38,290−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −21,849−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −20,346−100.0% | Sold out |
| Atria Investments LLC | 0 | $0 | 0.00% | −18,928−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −15,980−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −11,752−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −10,200−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −6,200−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −5,400−100.0% | Sold out |
| Values First Advisors, Inc. | 0 | $0 | 0.00% | −1,546−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −272−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −248−100.0% | Sold out |
| Bryn Mawr Trust Co | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −65−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| TFC Financial Management | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Ghost Tree Capital, LLC | – | – | – | – | Not filed |
| PEAK6 Investments LLC | – | – | – | – | Not filed |